Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

716
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
716
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

3.4K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.4K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

547
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
547
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.1K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

931
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
931
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

426
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
426

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improvement in Lead-Related Tricuspid Regurgitation Following Transvenous Lead Extraction: A Prospective Multicenter Study.

Heart rhythm·2026
Same author

Pulmonary Vein Isolation Plus Adjunct Techniques Versus Pulmonary Vein Isolation Alone for Persistent Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Journal of cardiovascular electrophysiology·2026
Same author

MOF-Derived Bi<sub>2</sub>WO<sub>6</sub>/MXene Ternary Heterojunction as a Highly Efficient Piezocatalyst for Ultrasound-Driven Hydrogen Evolution and Oxygen Evolution Reaction.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Contained pulmonary vein injury presenting as a hemorrhagic bulla post-pulsed field ablation: A case report.

HeartRhythm case reports·2026
Same author

Pulmonary Vein Isolation: Comparing different energy sources - independent or complementary use?

Indian pacing and electrophysiology journal·2026
Same author

Life-Threatening Delayed Myocardial Ischemia, Ventricular Arrhythmias, and SCD After PFA of AF: An Extended Case Series.

JACC. Clinical electrophysiology·2026

Related Experiment Video

Updated: Mar 2, 2026

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

20.3K

Atrial Fibrillation Ablation: First-Line Therapy?

Atul Verma1

  • 1Southlake Heart Rhythm Program, Division of Cardiology, Southlake Regional Health Centre, Newmarket, Ontario, Canada.

Journal of Atrial Fibrillation
|May 13, 2017
PubMed
Summary

Atrial fibrillation (AF) ablation is a safe and effective treatment. Evidence suggests AF ablation may be superior to drug therapy as a first-line treatment for patients with this heart rhythm disorder.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) is a common arrhythmia associated with increased morbidity and mortality.
  • Current drug therapies for AF are often ineffective and can carry significant risks.
  • Ablation is a recognized treatment for AF, typically used after drug therapy failure.

Purpose of the Study:

  • To present the rationale for considering catheter ablation as a first-line therapy for atrial fibrillation.
  • To evaluate the efficacy and safety of AF ablation compared to traditional drug management.

Main Methods:

  • This article reviews existing literature and clinical evidence regarding AF ablation versus drug therapy.
  • It analyzes the effectiveness, safety, and long-term outcomes of both treatment modalities.
Keywords:
Atrial fibrillationCatheter AblationPulmonary VeinsReview

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.2K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.9K

Related Experiment Videos

Last Updated: Mar 2, 2026

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

20.3K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.2K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.9K

Main Results:

  • Drug therapy for AF demonstrates limited efficacy and potential adverse effects on patient outcomes.
  • Catheter ablation targets the root causes of AF, offering potentially curative results with improved consistency and outcomes.
  • The complication rate associated with AF ablation is acceptably low.
  • Preliminary data suggest AF ablation may outperform drug therapy as an initial treatment.

Conclusions:

  • Atrial fibrillation ablation is a rapidly advancing treatment option.
  • It is increasingly considered for first-line therapy in select patients with debilitating AF.
  • The shift towards first-line ablation represents a significant evolution in AF management.